3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.

Source:http://linkedlifedata.com/resource/pubmed/id/8246131

Download in:

View as

General Info

PMID
8246131